日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes and recurrence patterns in pancreatic ductal adenocarcinoma diagnosed at an early stage: insights from a multicenter cohort study in Japan

日本一项多中心队列研究揭示了早期胰腺导管腺癌的临床结局和复发模式:

Ikemoto, Juri; Ishii, Yasutaka; Hanada, Keiji; Sasaki, Tamito; Fujimoto, Yoshifumi; Yamaguchi, Atsushi; Noma, Bunjiro; Minami, Tomoyuki; Yukutake, Masanobu; Okazaki, Akihito; Mouri, Teruo; Nakamura, Shinya; Uemura, Kenichiro; Takahashi, Shinya; Arihiro, Koji; Oka, Shiro

Very rare myoepithelial carcinoma occurred in the humerus: a case report

肱骨发生罕见肌上皮癌:病例报告

Furuta, Taisuke; Sakuda, Tomohiko; Yoshioka, Koki; Arihiro, Koji; Adachi, Nobuo

Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

血清IL-6浓度是预测阿特珠单抗联合贝伐珠单抗治疗肝细胞癌患者疗效的有效生物标志物。

Miura, Ryoichi; Ono, Atsushi; Nakahara, Hikaru; Shirane, Yuki; Yamaoka, Kenji; Fujii, Yasutoshi; Uchikawa, Shinsuke; Fujino, Hatsue; Murakami, Eisuke; Kawaoka, Tomokazu; Miki, Daiki; Tsuge, Masataka; Kishi, Takeshi; Ohishi, Waka; Sakamoto, Naoya; Arihiro, Koji; Hayes, Clair Nelson; Oka, Shiro

Roles of Tumor-Infiltrating Lymphocytes and Antitumor Immune Responses as Predictive and Prognostic Markers in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy

肿瘤浸润淋巴细胞和抗肿瘤免疫反应作为乳腺癌新辅助化疗患者预测和预后标志物的作用

Kim, Ryungsa; Kin, Takanori; Arihiro, Koji

Real-world data analysis for factors influencing the quality check status in FoundationOne CDx cancer genomic profiling tests

针对影响 FoundationOne CDx 癌症基因组分析检测质量检查状态的因素,开展真实世界数据分析

Niitsu, Hiroaki; Nakahara, Hikaru; Ishida, Katsunari; Kaneko, Yoshie; Hayes, C Nelson; Arihiro, Koji; Hinoi, Takao

Diversity of ER-positive and HER2-negative breast cancer stem cells attained using selective culture techniques

利用选择性培养技术获得的ER阳性和HER2阴性乳腺癌干细胞的多样性

Sueoka, Satoshi; Kai, Azusa; Kobayashi, Yukino; Ito, Masaoki; Sasada, Shinsuke; Emi, Akiko; Gotoh, Noriko; Arihiro, Koji; Nakayama, Koh; Okada, Morihito; Kadoya, Takayuki

Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development

肝脏分子失调导致非病毒相关肝细胞癌发生的多组学分析

Nakahara, Hikaru; Ono, Atsushi; Hayes, C Nelson; Shirane, Yuki; Miura, Ryoichi; Fujii, Yasutoshi; Tamura, Yosuke; Uchikawa, Shinsuke; Fujino, Hatsue; Nakahara, Takashi; Murakami, Eisuke; Yamauchi, Masami; Kawaoka, Tomokazu; Miki, Daiki; Tsuge, Masataka; Kobayashi, Tsuyoshi; Ohdan, Hideki; Arihiro, Koji; Oka, Shiro

Clinicopathological Features of Small Pancreatic Neuroendocrine Neoplasms 10 mm or Smaller

直径小于等于10毫米的小型胰腺神经内分泌肿瘤的临床病理特征

Hirano, Tetsuro; Serikawa, Masahiro; Ishii, Yasutaka; Nakamura, Shinya; Ikemoto, Juri; Furukawa, Masaru; Yamashita, Yumiko; Iijima, Noriaki; Okuda, Yasuhiro; Nomura, Risa; Arihiro, Koji; Uemura, Kenichiro; Takahashi, Shinya; Ohdan, Hideki; Oka, Shiro

Exploring the possibility of omitting axillary surgery in patients with clinical node-positive breast cancer achieving ypT0 after neoadjuvant chemotherapy

探讨对于新辅助化疗后达到ypT0的临床淋巴结阳性乳腺癌患者,是否可以省略腋窝手术

Shigematsu, Hideo; Takaya, Momoko; Suzuki, Kanako; Fujimoto, Mutsumi; Ikejiri, Haruka; Amioka, Ai; Hiraoka, Emiko; Sasada, Shinsuke; Arihiro, Koji; Okada, Morihito

Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation

评估经针吸活检诊断为导管原位癌且符合射频消融治疗条件的患者中,漏诊浸润性乳腺癌的风险

Shigematsu, Hideo; Fujimoto, Mutsumi; Suzuki, Kanako; Ikejiri, Haruka; Amioka, Ai; Hiraoka, Emiko; Sasada, Shinsuke; Arihiro, Koji; Okada, Morihito